Pulmatrix

PULMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.209 M

$1.70 +1.19%

Close of 22 Sept 2026

Revenue

$7.81M

#3202 by revenue

Earnings

-$5.16M

Loss-making

Shares outstanding

3,652,285

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#454Lexaria BioscienceLEXX$6.78M
#455GelteqGELS$6.53M
#456PulmatrixPULM$6.21M
#457Ernexa TherapeuticsERNA$6.20M
#458Bio Green Med SolutionBGMS$6.14M

What if Pulmatrix were worth as much as…

Open the what-if tool →

Gold $30.2T

$8,278,096

Per share 4,869,468× higher

Bitcoin $1.74T

$476,867.20

Per share 280,510× higher

Nvidia $5.52T

$1,510,223

Per share 888,367× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Pulmatrix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.